ArticlePharmaceutics2025

Plasma Protein Binding, Biostability, Metabolite Profiling, and CYP450 Phenotype of TPB15 Across Different Species: A Novel Smoothened Inhibitor for TNBC Therapy.

Dingsheng Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.